Pulsed electrostatic fields (ETG) to reduce hair loss in women undergoing chemotherapy for breast carcinoma: A pilot study

Aims: To determine whether specific pulsed electrostatic fields, or electrotrichogenesis (ETG), could potentially prevent or reduce hair loss in patients undergoing adjuvant cyclophosphamide, methotrexate and 5‐fluorouracil (CMF) chemotherapy for breast cancer. Methods: Thirteen women were followed...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Psycho-oncology (Chichester, England) England), 2002-05, Vol.11 (3), p.244-248
Hauptverfasser:	Benjamin, Benji, Ziginskas, Danute, Harman, John, Meakin, Timothy
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Alopecia - etiology Alopecia - therapy Antineoplastic Agents - adverse effects Breast cancer Breast Neoplasms - drug therapy Breast Neoplasms - psychology Chemotherapy Electric Stimulation Therapy - methods Electricity Electrotrichogenesis Female Hair loss Humans Middle Aged New Zealand Patients Pilot Projects Pulsed electrostatic fields Reduction
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page	248
container_issue	3
container_start_page	244
container_title	Psycho-oncology (Chichester, England)
container_volume	11
creator	Benjamin, Benji Ziginskas, Danute Harman, John Meakin, Timothy
description	Aims: To determine whether specific pulsed electrostatic fields, or electrotrichogenesis (ETG), could potentially prevent or reduce hair loss in patients undergoing adjuvant cyclophosphamide, methotrexate and 5‐fluorouracil (CMF) chemotherapy for breast cancer. Methods: Thirteen women were followed during their adjuvant ETG and chemotherapy treatment to determine the efficacy of ETG. All patients were treated for 12 min, twice weekly with a pulsed electrostatic field. Quantitative hair loss was measured by photographic assessment, and manual hair count. Quality of life assessment was conducted at the end of the study. Results: Twelve out of 13 participants had good hair retention throughout the chemotherapy period and afterwards. There were no reported side effects attributable to ETG. Conclusions: This study shows encouraging results in an area where no other appropriate treatment is available Reducing alopecia, secondary to chemotherapy has the potential to increase CMF treatment compliance, enhance patient self‐esteem, and improve overall quality of life during this stressful period Copyright © 2002 John Wiley & Sons, Ltd.
doi_str_mv	10.1002/pon.593
format	Article
fullrecord	<record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_764149348</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>57371984</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4803-fcd659ac54887cbe28cd94a812ee04dcebce6120cbc3f273a53d7fa653031d8c3</originalsourceid><addsrcrecordid>eNqF0ctO3DAUBmCralUorfoGlVe9CIXasZ3Y3SEuUyQEI0HVpeXYJ4zbJA62I5g-PUEzKivalc_i03-O_CP0npIDSkj5dQzDgVDsBdqlRKmCVpS-fJxFXaiSqx30JqVfhMxWVa_RDi0pLbkUu-jPcuoSOAwd2BxDyiZ7i1sPnUv488n14gvOAUdwkwW8Mj7iLqSE_YDvQg8DngYH8Sb44QbbFfQhryCacY3bEHETwaSMrYnWD6E33_AhHn0XMk55cuu36FVr5uXvtu8e-nF6cn30vTi_XJwdHZ4XlkvCita6SihjBZeytg2U0jrFjaQlAOHOQmOhoiWxjWVtWTMjmKtbUwlGGHXSsj30aZM7xnA7Qcq698lC15kBwpR0XXHKFeNylh__LamUhFP1XyhqVlMl-dNuO_9titDqMfrexLWmRD82p-fm9NzcLD9sI6emB_fktlXNYH8D7nwH6-dy9PLyYhNXbLRPGe7_ahN_62o-TuifFwutqvqKni6P9RV7AOZasfo</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>57371984</pqid></control><display><type>article</type><title>Pulsed electrostatic fields (ETG) to reduce hair loss in women undergoing chemotherapy for breast carcinoma: A pilot study</title><source>MEDLINE</source><source>Wiley Journals</source><source>Applied Social Sciences Index & Abstracts (ASSIA)</source><creator>Benjamin, Benji ; Ziginskas, Danute ; Harman, John ; Meakin, Timothy</creator><creatorcontrib>Benjamin, Benji ; Ziginskas, Danute ; Harman, John ; Meakin, Timothy</creatorcontrib><description>Aims: To determine whether specific pulsed electrostatic fields, or electrotrichogenesis (ETG), could potentially prevent or reduce hair loss in patients undergoing adjuvant cyclophosphamide, methotrexate and 5‐fluorouracil (CMF) chemotherapy for breast cancer. Methods: Thirteen women were followed during their adjuvant ETG and chemotherapy treatment to determine the efficacy of ETG. All patients were treated for 12 min, twice weekly with a pulsed electrostatic field. Quantitative hair loss was measured by photographic assessment, and manual hair count. Quality of life assessment was conducted at the end of the study. Results: Twelve out of 13 participants had good hair retention throughout the chemotherapy period and afterwards. There were no reported side effects attributable to ETG. Conclusions: This study shows encouraging results in an area where no other appropriate treatment is available Reducing alopecia, secondary to chemotherapy has the potential to increase CMF treatment compliance, enhance patient self‐esteem, and improve overall quality of life during this stressful period Copyright © 2002 John Wiley & Sons, Ltd.</description><identifier>ISSN: 1057-9249</identifier><identifier>EISSN: 1099-1611</identifier><identifier>DOI: 10.1002/pon.593</identifier><identifier>PMID: 12112485</identifier><identifier>CODEN: POJCEE</identifier><language>eng</language><publisher>Chichester, UK: John Wiley & Sons, Ltd</publisher><subject>Adult ; Alopecia - etiology ; Alopecia - therapy ; Antineoplastic Agents - adverse effects ; Breast cancer ; Breast Neoplasms - drug therapy ; Breast Neoplasms - psychology ; Chemotherapy ; Electric Stimulation Therapy - methods ; Electricity ; Electrotrichogenesis ; Female ; Hair loss ; Humans ; Middle Aged ; New Zealand ; Patients ; Pilot Projects ; Pulsed electrostatic fields ; Reduction</subject><ispartof>Psycho-oncology (Chichester, England), 2002-05, Vol.11 (3), p.244-248</ispartof><rights>Copyright © 2002 John Wiley & Sons, Ltd.</rights><rights>Copyright 2002 John Wiley & Sons, Ltd.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4803-fcd659ac54887cbe28cd94a812ee04dcebce6120cbc3f273a53d7fa653031d8c3</citedby><cites>FETCH-LOGICAL-c4803-fcd659ac54887cbe28cd94a812ee04dcebce6120cbc3f273a53d7fa653031d8c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fpon.593$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fpon.593$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,31000,45574,45575</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12112485$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Benjamin, Benji</creatorcontrib><creatorcontrib>Ziginskas, Danute</creatorcontrib><creatorcontrib>Harman, John</creatorcontrib><creatorcontrib>Meakin, Timothy</creatorcontrib><title>Pulsed electrostatic fields (ETG) to reduce hair loss in women undergoing chemotherapy for breast carcinoma: A pilot study</title><title>Psycho-oncology (Chichester, England)</title><addtitle>Psycho-Oncology</addtitle><description>Aims: To determine whether specific pulsed electrostatic fields, or electrotrichogenesis (ETG), could potentially prevent or reduce hair loss in patients undergoing adjuvant cyclophosphamide, methotrexate and 5‐fluorouracil (CMF) chemotherapy for breast cancer. Methods: Thirteen women were followed during their adjuvant ETG and chemotherapy treatment to determine the efficacy of ETG. All patients were treated for 12 min, twice weekly with a pulsed electrostatic field. Quantitative hair loss was measured by photographic assessment, and manual hair count. Quality of life assessment was conducted at the end of the study. Results: Twelve out of 13 participants had good hair retention throughout the chemotherapy period and afterwards. There were no reported side effects attributable to ETG. Conclusions: This study shows encouraging results in an area where no other appropriate treatment is available Reducing alopecia, secondary to chemotherapy has the potential to increase CMF treatment compliance, enhance patient self‐esteem, and improve overall quality of life during this stressful period Copyright © 2002 John Wiley & Sons, Ltd.</description><subject>Adult</subject><subject>Alopecia - etiology</subject><subject>Alopecia - therapy</subject><subject>Antineoplastic Agents - adverse effects</subject><subject>Breast cancer</subject><subject>Breast Neoplasms - drug therapy</subject><subject>Breast Neoplasms - psychology</subject><subject>Chemotherapy</subject><subject>Electric Stimulation Therapy - methods</subject><subject>Electricity</subject><subject>Electrotrichogenesis</subject><subject>Female</subject><subject>Hair loss</subject><subject>Humans</subject><subject>Middle Aged</subject><subject>New Zealand</subject><subject>Patients</subject><subject>Pilot Projects</subject><subject>Pulsed electrostatic fields</subject><subject>Reduction</subject><issn>1057-9249</issn><issn>1099-1611</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>7QJ</sourceid><recordid>eNqF0ctO3DAUBmCralUorfoGlVe9CIXasZ3Y3SEuUyQEI0HVpeXYJ4zbJA62I5g-PUEzKivalc_i03-O_CP0npIDSkj5dQzDgVDsBdqlRKmCVpS-fJxFXaiSqx30JqVfhMxWVa_RDi0pLbkUu-jPcuoSOAwd2BxDyiZ7i1sPnUv488n14gvOAUdwkwW8Mj7iLqSE_YDvQg8DngYH8Sb44QbbFfQhryCacY3bEHETwaSMrYnWD6E33_AhHn0XMk55cuu36FVr5uXvtu8e-nF6cn30vTi_XJwdHZ4XlkvCita6SihjBZeytg2U0jrFjaQlAOHOQmOhoiWxjWVtWTMjmKtbUwlGGHXSsj30aZM7xnA7Qcq698lC15kBwpR0XXHKFeNylh__LamUhFP1XyhqVlMl-dNuO_9titDqMfrexLWmRD82p-fm9NzcLD9sI6emB_fktlXNYH8D7nwH6-dy9PLyYhNXbLRPGe7_ahN_62o-TuifFwutqvqKni6P9RV7AOZasfo</recordid><startdate>200205</startdate><enddate>200205</enddate><creator>Benjamin, Benji</creator><creator>Ziginskas, Danute</creator><creator>Harman, John</creator><creator>Meakin, Timothy</creator><general>John Wiley & Sons, Ltd</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QJ</scope><scope>7X8</scope><scope>ASE</scope><scope>FPQ</scope><scope>K6X</scope></search><sort><creationdate>200205</creationdate><title>Pulsed electrostatic fields (ETG) to reduce hair loss in women undergoing chemotherapy for breast carcinoma: A pilot study</title><author>Benjamin, Benji ; Ziginskas, Danute ; Harman, John ; Meakin, Timothy</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4803-fcd659ac54887cbe28cd94a812ee04dcebce6120cbc3f273a53d7fa653031d8c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Adult</topic><topic>Alopecia - etiology</topic><topic>Alopecia - therapy</topic><topic>Antineoplastic Agents - adverse effects</topic><topic>Breast cancer</topic><topic>Breast Neoplasms - drug therapy</topic><topic>Breast Neoplasms - psychology</topic><topic>Chemotherapy</topic><topic>Electric Stimulation Therapy - methods</topic><topic>Electricity</topic><topic>Electrotrichogenesis</topic><topic>Female</topic><topic>Hair loss</topic><topic>Humans</topic><topic>Middle Aged</topic><topic>New Zealand</topic><topic>Patients</topic><topic>Pilot Projects</topic><topic>Pulsed electrostatic fields</topic><topic>Reduction</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Benjamin, Benji</creatorcontrib><creatorcontrib>Ziginskas, Danute</creatorcontrib><creatorcontrib>Harman, John</creatorcontrib><creatorcontrib>Meakin, Timothy</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Applied Social Sciences Index & Abstracts (ASSIA)</collection><collection>MEDLINE - Academic</collection><collection>British Nursing Index</collection><collection>British Nursing Index (BNI) (1985 to Present)</collection><collection>British Nursing Index</collection><jtitle>Psycho-oncology (Chichester, England)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Benjamin, Benji</au><au>Ziginskas, Danute</au><au>Harman, John</au><au>Meakin, Timothy</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pulsed electrostatic fields (ETG) to reduce hair loss in women undergoing chemotherapy for breast carcinoma: A pilot study</atitle><jtitle>Psycho-oncology (Chichester, England)</jtitle><addtitle>Psycho-Oncology</addtitle><date>2002-05</date><risdate>2002</risdate><volume>11</volume><issue>3</issue><spage>244</spage><epage>248</epage><pages>244-248</pages><issn>1057-9249</issn><eissn>1099-1611</eissn><coden>POJCEE</coden><abstract>Aims: To determine whether specific pulsed electrostatic fields, or electrotrichogenesis (ETG), could potentially prevent or reduce hair loss in patients undergoing adjuvant cyclophosphamide, methotrexate and 5‐fluorouracil (CMF) chemotherapy for breast cancer. Methods: Thirteen women were followed during their adjuvant ETG and chemotherapy treatment to determine the efficacy of ETG. All patients were treated for 12 min, twice weekly with a pulsed electrostatic field. Quantitative hair loss was measured by photographic assessment, and manual hair count. Quality of life assessment was conducted at the end of the study. Results: Twelve out of 13 participants had good hair retention throughout the chemotherapy period and afterwards. There were no reported side effects attributable to ETG. Conclusions: This study shows encouraging results in an area where no other appropriate treatment is available Reducing alopecia, secondary to chemotherapy has the potential to increase CMF treatment compliance, enhance patient self‐esteem, and improve overall quality of life during this stressful period Copyright © 2002 John Wiley & Sons, Ltd.</abstract><cop>Chichester, UK</cop><pub>John Wiley & Sons, Ltd</pub><pmid>12112485</pmid><doi>10.1002/pon.593</doi><tpages>5</tpages></addata></record>
fulltext	fulltext
identifier	ISSN: 1057-9249
ispartof	Psycho-oncology (Chichester, England), 2002-05, Vol.11 (3), p.244-248
issn	1057-9249 1099-1611
language	eng
recordid	cdi_proquest_miscellaneous_764149348
source	MEDLINE; Wiley Journals; Applied Social Sciences Index & Abstracts (ASSIA)
subjects	Adult Alopecia - etiology Alopecia - therapy Antineoplastic Agents - adverse effects Breast cancer Breast Neoplasms - drug therapy Breast Neoplasms - psychology Chemotherapy Electric Stimulation Therapy - methods Electricity Electrotrichogenesis Female Hair loss Humans Middle Aged New Zealand Patients Pilot Projects Pulsed electrostatic fields Reduction
title	Pulsed electrostatic fields (ETG) to reduce hair loss in women undergoing chemotherapy for breast carcinoma: A pilot study
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T07%3A37%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pulsed%20electrostatic%20fields%20(ETG)%20to%20reduce%20hair%20loss%20in%20women%20undergoing%20chemotherapy%20for%20breast%20carcinoma:%20A%20pilot%20study&rft.jtitle=Psycho-oncology%20(Chichester,%20England)&rft.au=Benjamin,%20Benji&rft.date=2002-05&rft.volume=11&rft.issue=3&rft.spage=244&rft.epage=248&rft.pages=244-248&rft.issn=1057-9249&rft.eissn=1099-1611&rft.coden=POJCEE&rft_id=info:doi/10.1002/pon.593&rft_dat=%3Cproquest_cross%3E57371984%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=57371984&rft_id=info:pmid/12112485&rfr_iscdi=true